Tag: BMIObesity
Body mass index (BMI): Weight in kilograms divided by the square of height in meters (kg/m2). Underweight—BMI < 18.5 kg/m2; normal weight—18.5 to <25; overweight—25 to <30; obese—30 to <35; severely obese—35 to <40; and morbidly obese—≥40.
Articles
- Breast cancer patients who gain weight after diagnosis have worse prognosis
- Influence of BMI, metabolic syndrome and diabetes on triple negative breast cancer prognosis
- Obesity increases risk of breast cancer and worsens prognosis
News
- 02/15/21
- Time-restricted eating inhibits mammary tumor growth in obese mice
- 08/22/20
- Soy protein diet results in more mammary tumors than casein diet in obese mice
- 06/17/18
- Weight loss surgery linked to improved outcomes among early-stage breast cancer survivors
- 01/15/17
- Weight loss after breast cancer diagnosis does not necessarily improve survival
- 08/29/16
- Use of calcium channel blockers linked to risk of breast cancer, especially among overweight women
- 09/14/14
- Omega-3 fats reduce obesity-induced tumor progression in mouse model of breast cancer
- 07/19/12
- Aromatase inhibitors are less effective in reducing estrogen in women with high BMI
- 06/20/12
- Large breast size linked to reduced survival for ER+ breast cancer
- 12/30/11
- Body weight at diagnosis influences breast cancer survival
- 10/19/11
- Tumor response to anti-estrogen treatment before surgery is influenced by BMI and race
- 01/01/11
- High waist to hip ratio more strongly associated with risk of ER negative breast cancer
Studies
-
Early-Life and Adult Adiposity, Adult Height, and Benign Breast Tissue Composition
Cite
Oh H, Yaghjyan L, Austin-Datta RJ, Heng YJ, Baker GM, Sirinukunwattana K, et al. Early-Life and Adult Adiposity, Adult Height, and Benign Breast Tissue Composition. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 30:608-615 10.1158/1055-9965.epi-20-1348
-
Dietary Inflammatory Potential and Risk of Breast Cancer: A Population-based Case-control Study in France (CECILE Study)
Cite
Hajji-Louati M, Cordina-Duverger E, Laouali N, Mancini F, Guénel P. Dietary Inflammatory Potential and Risk of Breast Cancer: A Population-based Case-control Study in France (CECILE Study). Research Square Platform LLC; 2021; 10.21203/rs.3.rs-397246/v1
-
Protein intake, weight loss, dietary intervention, and worsening of quality of life in older patients during chemotherapy for cancer
Cite
Regueme SC, Echeverria I, Monéger N, Durrieu J, Becerro-Hallard M, Duc S, et al. Protein intake, weight loss, dietary intervention, and worsening of quality of life in older patients during chemotherapy for cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 29:687-696 10.1007/s00520-020-05528-4
-
Body Mass Index and Risk of Second Cancer among Women with Breast Cancer
Cite
Feigelson HS, Bodelon C, Powers JD, Curtis RE, Buist DSM, Veiga LHS, et al. Body Mass Index and Risk of Second Cancer among Women with Breast Cancer. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 10.1093/jnci/djab053
-
Multilevel Risk Factors for Weight Change after Breast Cancer Diagnosis Among Black Women
Cite
Kim K, Bandera E, Xu B, Chanumolu D, Rundle A, Hurvitz P, et al. Multilevel Risk Factors for Weight Change after Breast Cancer Diagnosis Among Black Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021; 30:806.2-806 10.1158/1055-9965.epi-21-0213
-
Contribution of the tumor and obese microenvironment to triple negative breast cancer
Cite
Kaul K, Misri S, Ramaswamy B, Ganju RK. Contribution of the tumor and obese microenvironment to triple negative breast cancer. Cancer Letters. Elsevier BV; 2021; 10.1016/j.canlet.2021.03.024
-
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
Cite
Dong S, Wang Z, Shen K, Chen X. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis. Frontiers in Oncology. Frontiers Media SA; 2021; 11 10.3389/fonc.2021.629666
-
Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Cite
Ellingjord-Dale M, Christakoudi S, Weiderpass E, Panico S, Dossus L, Olsen A, et al. Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. International Journal of Epidemiology. Oxford University Press (OUP); 2021; 10.1093/ije/dyab032
-
Weight regain and breast cancer-related biomarkers following an exercise intervention in postmenopausal women
Cite
Gonzalo-Encabo P, McNeil J, Pérez-López A, Valadés D, Courneya KS, Friedenreich CM. Weight regain and breast cancer-related biomarkers following an exercise intervention in postmenopausal women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1652.2020 10.1158/1055-9965.epi-20-1652
-
The effect of bariatric surgery on breast cancer incidence and characteristics: A meta-analysis and systematic review
Cite
Lovrics O, Butt J, Lee Y, Lovrics P, Boudreau V, Anvari M, et al. The effect of bariatric surgery on breast cancer incidence and characteristics: A meta-analysis and systematic review. The American Journal of Surgery. Elsevier BV; 2021; 10.1016/j.amjsurg.2021.03.016
-
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
Cite
Smith SG, Sestak I, Morris MA, Harvie M, Howell A, Forbes J, et al. The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06141-7
-
Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population‐based study in Icelandic women
Cite
Noh H, Charvat H, Freisling H, Ólafsdóttir GH, Ólafsdóttir EJ, Tryggvadóttir L, et al. Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population‐based study in Icelandic women. International Journal of Cancer. Wiley; 2019; 147:793-802 10.1002/ijc.32805
-
Weight Changes According to Treatment in a Diverse Cohort of Breast Cancer Patients
Cite
Fukui J, White K, Frankland T, Oshiro C, Wilkens L. Weight Changes According to Treatment in a Diverse Cohort of Breast Cancer Patients. Research Square; 2021; 10.21203/rs.3.rs-260561/v1
-
Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations
Cite
Iyengar NM, Zhou XK, Mendieta H, El-Hely O, Giri DD, Winston L, et al. Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00226-8
-
Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer
Cite
Iyengar NM, Zhou XK, Mendieta H, Giri DD, El-Hely O, Winston L, et al. Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer. Cancer Prevention Research. American Association for Cancer Research (AACR); 2021;:canprevres.CAPR-20-0507-E.2020 10.1158/1940-6207.capr-20-0507
-
Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study
Cite
Koyratty N, McCann SE, Millen AE, Nie J, Trevisan M, Freudenheim JL. Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1242.2020 10.1158/1055-9965.epi-20-1242
-
Association of Obesity with Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis
Cite
Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E, et al. Association of Obesity with Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 10.1093/jnci/djab023
-
An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors
Cite
KREKLAU A, NEL I, KASIMIR-BAUER S, KIMMIG R, FRACKENPOHL AC, AKTAS B. An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors. In Vivo. Anticancer Research USA Inc.; 2021; 35:1007-1015 10.21873/invivo.12344
-
Molecular insights into the interplay between adiposity, breast cancer and bone metastasis
Cite
Soni S, Torvund M, Mandal CC. Molecular insights into the interplay between adiposity, breast cancer and bone metastasis. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2021; 10.1007/s10585-021-10076-0
-
Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients
Cite
Shang L, Hattori M, Fleming G, Jaskowiak N, Hedeker D, Olopade OI, et al. Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01397-9
-
Interrelationship of Seasons with Inflammation, Red Meat, Fruit, and Vegetable Intakes, Cardio-Metabolic Health, and Smoking Status among Breast Cancer Survivors
Cite
Wu T, Shinde R, Castro R, Pierce J. Interrelationship of Seasons with Inflammation, Red Meat, Fruit, and Vegetable Intakes, Cardio-Metabolic Health, and Smoking Status among Breast Cancer Survivors. Journal of Clinical Medicine. MDPI AG; 2021; 10:636 10.3390/jcm10040636
-
Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models
Cite
Das M, Ellies LG, Kumar D, Sauceda C, Oberg A, Gross E, et al. Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-020-20743-7
-
Breast cancer risk factors and survival by tumor subtype: pooled analyses from the Breast Cancer Association Consortium
Cite
Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Cluver H, et al. Breast cancer risk factors and survival by tumor subtype: pooled analyses from the Breast Cancer Association Consortium. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.0924.2020 10.1158/1055-9965.epi-20-0924
-
Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative
Cite
Yuan Y, Pan K, Mortimer J, Chlebowski RT, Luo J, Yan JE, et al. Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative. Cancer. Wiley; 2021; 10.1002/cncr.33407
-
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
Cite
Shirdarreh M, Pezo RC. Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review. Breast Cancer. Springer Science and Business Media LLC; 2021; 10.1007/s12282-020-01213-w
-
Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
Cite
Kennard K, Buckley ME, Sizer LM, Larson S, Carter WB, Frazier TG, et al. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06034-1
-
Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: A Mixed‐Methods Study
Cite
Kruif AJ, Westerman MJ, Winkels RM, Koster MS, Staaij IM, Berg MMGA, et al. Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: A Mixed‐Methods Study. Journal of Human Nutrition and Dietetics. Wiley; 2021; 10.1111/jhn.12843
-
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial
Cite
Samuel Martel , Matteo Lambertini , Dominique Agbor-Tarh , Noam F. Ponde , Andrea Gombos , Vicki Paterson , et al. Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial. Journal of the National Comprehensive Cancer Network. National Comprehensive Cancer Network; 2021;:1-9. 10.6004/jnccn.2020.7606
-
COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice
Cite
Gonçalves RM, Delgobo M, Agnes JP, das Neves RN, Falchetti M, Casagrande T, et al. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. Cancer Letters. Elsevier BV; 2021; 10.1016/j.canlet.2021.01.003
-
Central adiposity and subsequent risk of breast cancer by menopause status
Cite
Houghton SC, Eliassen H, Tamimi RM, Willett WC, Rosner BA, Hankinson SE. Central adiposity and subsequent risk of breast cancer by menopause status. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 10.1093/jnci/djaa197
-
Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer
Cite
Nyrop KA, Damone EM, Deal AM, Carey LA, Lorentsen M, Shachar SS, et al. Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer. Cancer. Wiley; 2020; 10.1002/cncr.33288
-
Effects of obesity on NK cells in a mouse model of postmenopausal breast cancer
Cite
Spielmann J, Mattheis L, Jung J, Rauße H, Glaß M, Bähr I, et al. Effects of obesity on NK cells in a mouse model of postmenopausal breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-76906-5
-
The Tumor–Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy
Cite
Cho H, Park M, Park H, Ko ES, Hwang NY, Im Y, et al. The Tumor–Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy. Biology. MDPI AG; 2020; 9:391 10.3390/biology9110391
-
Increased adiposity is protective for breast and prostate cancer: a Mendelian randomisation study using up to 132,413 breast cancer cases and 85,907 prostate cancer cases
Cite
Amin HA, Kaewsri P, Yiorkas AM, Cooke H, Blakemore AI, Drenos F. Increased adiposity is protective for breast and prostate cancer: a Mendelian randomisation study using up to 132,413 breast cancer cases and 85,907 prostate cancer cases. Cold Spring Harbor Laboratory; 2020; 10.1101/2020.04.02.20049031
-
Overweight Women with Breast Cancer on Chemotherapy Have More Unfavorable Inflammatory and Oxidative Stress Profiles
Cite
L. D. Santos L, D. D. Custódio I, Silva ATF, C. C. Ferreira I, C. Marinho E, C. Caixeta D, et al. Overweight Women with Breast Cancer on Chemotherapy Have More Unfavorable Inflammatory and Oxidative Stress Profiles. Nutrients. MDPI AG; 2020; 12:3303 10.3390/nu12113303
-
Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies
Cite
van den Brandt PA, Ziegler RG, Wang M, Hou T, Li R, Adami H, et al. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies. European Journal of Epidemiology. Springer Science and Business Media LLC; 2020; 10.1007/s10654-020-00688-3
-
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
Cite
Di Cosimo S, Porcu L, Agbor-tarh D, Cinieri S, Franzoi MA, De Santis MC, et al. Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01356-w
-
Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women
Cite
Park JW, Han K, Shin DW, Yeo Y, Chang JW, Yoo JE, et al. Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05952-4
-
Do Obese Patients Present With More Advanced Breast Cancer?
Cite
Wang M, Huang J, Chagpar AB. Do Obese Patients Present With More Advanced Breast Cancer?. The American Surgeon. SAGE Publications; 2020;:000313482094951 10.1177/0003134820949510
-
Effects of metformin on adipose-derived stromal cell (ADSC) – Breast cancer cell lines interaction
Cite
Teufelsbauer M, Rath B, Plangger A, Staud C, Nanobashvili J, Huk I, et al. Effects of metformin on adipose-derived stromal cell (ADSC) – Breast cancer cell lines interaction. Life Sciences. Elsevier BV; 2020; 261:118371 10.1016/j.lfs.2020.118371
-
Breast cancer endocrine therapy exhausts adipocyte progenitors promoting weight gain and glucose intolerance
Cite
Scalzo RL, Foright RM, Hull SE, Knaub LA, Johnson-Murguia S, Kinanee F, et al. Breast cancer endocrine therapy exhausts adipocyte progenitors promoting weight gain and glucose intolerance. Cold Spring Harbor Laboratory; 2020; 10.1101/2020.08.21.259440
-
The risk of female-specific cancer after bariatric surgery in the state of New York
Cite
Tsui ST, Yang J, Zhang X, Spaniolas K, Kim S, Griffin T, et al. The risk of female-specific cancer after bariatric surgery in the state of New York. Surgical Endoscopy. Springer Science and Business Media LLC; 2020; 10.1007/s00464-020-07915-8
-
Different body mass indexes and their relation to prognosis of early-stage breast cancer in postmenopausal Mexican-Mestizo women
Cite
Cárdenas-Cárdenas E, Tenorio-Torres A, Méndez JP, Orozco-Arguelles L, Leal-García M, Tejeda ME, et al. Different body mass indexes and their relation to prognosis of early-stage breast cancer in postmenopausal Mexican-Mestizo women. Women & Health. Informa UK Limited; 2020;:1-8 10.1080/03630242.2020.1812791
-
Obese adipose tissue extracellular vesicles raise breast cancer cell malignancy
Cite
Ramos-Andrade I, Moraes J, Brandão-Costa RM, Vargas da Silva S, de Souza A, da Silva C, et al. Obese adipose tissue extracellular vesicles raise breast cancer cell malignancy. Endocrine-Related Cancer. Bioscientifica; 2020; 27:571-582 10.1530/erc-19-0507
-
Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service
Cite
Hwang K, Han K, Oh S, Koo BK, Lee SK, Kim J, et al. Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2038-2047 10.1158/1055-9965.epi-20-0300
-
Abstract 4642: Effects of soy protein diet on plasma isoflavones levels in obese DMBA-induced mammary tumor rat model
Cite
Hakkak R, Korourian S. Abstract 4642: Effects of soy protein diet on plasma isoflavones levels in obese DMBA-induced mammary tumor rat model. Epidemiology. American Association for Cancer Research; 2020; 10.1158/1538-7445.am2020-4642
-
Abstract 3460: Effects of feeding soy protein isolate diet on hepatic methylation and oxidative stress in DMBA-induced mammary tumor in obese rat model
Cite
Hakkak R, Melnyk S, Korourian S. Abstract 3460: Effects of feeding soy protein isolate diet on hepatic methylation and oxidative stress in DMBA-induced mammary tumor in obese rat model. Molecular and Cellular Biology / Genetics. American Association for Cancer Research; 2020; 10.1158/1538-7445.am2020-3460
-
Abstract 2440: The epigenetic influence of maternal diet on prevention of high-fat diet induced obesity and breast cancer in later life
Cite
Li Y, Chen M, Tollefsbol T. Abstract 2440: The epigenetic influence of maternal diet on prevention of high-fat diet induced obesity and breast cancer in later life. Molecular and Cellular Biology / Genetics. American Association for Cancer Research; 2020; 10.1158/1538-7445.am2020-2440
-
Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status
Cite
Bissell MC, Kerlikowske K, Sprague BL, Tice JA, Gard CC, Tossas KY, et al. Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020;:cebp.0358.2020 10.1158/1055-9965.epi-20-0358
-
Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population‐based patient cohort study
Cite
Jung AY, Hüsing A, Behrens S, Krzykalla J, Obi N, Becher H, et al. Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population‐based patient cohort study. International Journal of Cancer. Wiley; 2020; 148:18-27 10.1002/ijc.33181
-
Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors
Cite
Raghavendra A, Sinha AK, Valle-Goffin J, Shen Y, Tripathy D, Barcenas CH. Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors. Clinical Breast Cancer. Elsevier BV; 2018; 18:e7-e13 10.1016/j.clbc.2017.11.006
-
Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review
Cite
Nyrop KA, Deal AM, Lee JT, Muss HB, Choi SK, Dixon S, et al. Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:375-388 10.1007/s10549-017-4106-y
-
The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model
Cite
Arumugam A, Lissner EA, Lakshmanaswamy R. The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model. Reproductive Biology and Endocrinology. Springer Science and Business Media LLC; 2014; 12:66 10.1186/1477-7827-12-66